Hear about the ECMC network’s work to better support young cancer patients

08 Dec 2021

One of the main reasons for a lack of progress in treating cancer in teenagers and young adults (TYA) is that this age group is less likely to participate in clinical trials than children or older adults. That’s why the ECMC Network set out to identify the key barriers and challenges to accessing clinical trials to ensure inclusivity and equity of access. 

How did we do this?
We captured experiences on the key challenges and brought people together at four workshops to discuss how we can work together. Representatives at the workshop included clinicians, nurses, patient advocates, industry and regulators.

What happens next?
Summarising and sharing what we’ve heard. Then we’ll prioritise and plan how we take this forward together. 

Hear from key members who have been involved in this work and why it is important to them.

Professor Andy Davies, Professor of Haematological Oncology at Southampton & Clinical Lead for TYA in Wessex

Dr Lynley Marshall, Oak Foundation Consultant in Paediatric and Adolescent Oncology Drug Development at The Royal Marsden Hospital

Professor Deborah Tweddle  Professor of Paediatric Oncology at Newcastle